A 1-(.beta.-L-ribofuranosyl)-1,2,4-triazole-3-carboxamide is administered in a method of treatment of a viral infection in a patient, including HIV infection, HCV infection, or BHV infection.

Un 1-(.beta.-L-ribofuranosyl)-1,2,4-triazole-3-carboxamide est administré dans une méthode de traitement d'une infection virale dans un patient, y compris l'infection par le HIV, l'infection de HCV, ou l'infection de BHV.

 
Web www.patentalert.com

< Peptide comprising the sequence CAFRQVC and methods using it

< Antigentically-marked non-infectious retrovirus-like particles

> Combinations comprising VX478, zidovudine and/or 1592U89 for use in the treatment of HIV

> Autonomous off-board defensive aids system

~ 00060